MaxCyte

MaxCyte® is a leading cell-engineering company advancing the discovery, development, and commercialization of next-generation cell therapies. The company's Flow Electroporation® technology and SeQure DX™ gene editing risk assessment services provide precise, efficient, and scalable solutions for cell engineering. Supported by comprehensive scientific, technical, and regulatory expertise, MaxCyte’s ExPERT™ platform enables researchers to engineer a wide range of cell types and payloads, accelerating the development of safe and effective treatments. With more than 25 years of experience in cell engineering, MaxCyte continues to shape the future of medicine.

Content by MaxCyte

Graphic showing a DNA strand and red blood cells

Moving Gene Editing Advances Into the Clinic

By The Scientist and MaxCyte | | 4 min read

Page 1 of 1 - 1 Total Items

August 2026 Digest cover

August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.

Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.

Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Learn practical strategies for optimizing sample preparation, fragmentation, library construction, and quality control to generate high-quality next-generation sequencing (NGS) data across a range of sample types.

Products

Product News

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.